FDA Sprinkles Some Rain On the PCSK9 Inhibitor Parade

Mar 7 2014, 5:58pm CST | by

In the last few years the PCSK9 inhibitors have been one of the few bright lights in an otherwise dismal field of new cardiovascular drugs. Now the FDA is raising questions that could dramatically slow down the progress of these new cholesterol-lowering drugs.

Last month Regeneron disclosed that it had been “advised by the FDA that it has become aware of neurocognitive adverse events in the PCSK9 inhibitor class. The FDA requested that Regeneron and its partner, Sanofi, “make an assessment of potential neurocognitive adverse events across the global development program” of their PCSK9 inhibitor, alirocumab. Regeneron and Sanofi said they were “not aware of any neurocognitive adverse event signal relating to alirocumab” but warned that “if this or another adverse event signal is detected, the further development of alirocumab may be delayed or fail, or its commercial value diminished.”

No one remarked on the statement last month when it was buried in the Regeneron annual report. But when the same statement was discovered today in Sanofi’s annual report, a Twitter storm ensued, and the companies’ stocks, as well as Amgen’s (which is also developing a PCSK9 inhibitor) took significant hits.

Reporters and analysts asked around but found no obvious source for the FDA’s concerns. Regeneron, Sanofi, Amgen, and Pfizer all denied finding any signal for neurocognitive adverse events in their data.

Short of the remote possibility that neurocognitive adverse events could scuttle the entire class of drugs, a more likely problem is that these concerns could result in serious delays in the approval of these drugs, which many thought were on a smooth path to approval. Most ominously, the companies said that the FDA asked “about the feasibility of incorporating neurocognitive testing into at least a subset of patients” in clinical trials. The conventional wisdom has been that the PCSK9 inhibitors will be able to gain approval before the completion of outcome studies. The concern now is that the FDA will insist that these studies be completed before the drugs can be approved.

Source: Forbes Business

 
 

Don't miss ...

 

<a href="/latest_stories/all/all/30" rel="author">Forbes</a>
Forbes is among the most trusted resources for the world's business and investment leaders, providing them the uncompromising commentary, concise analysis, relevant tools and real-time reporting they need to succeed at work, profit from investing and have fun with the rewards of winning.

 

blog comments powered by Disqus

Latest stories

Ebola virus detected in semen three months after symptoms end
Geneva, Nov 28 (IANS/EFE) The World Health Organisation (WHO) warned Friday that the semen of men recovering from Ebola can contain the deadly virus up to three months after the symptoms disappear.
 
 
Hitachi evinces interest in developing Andhra ports
Hyderabad, Nov 28 (IANS) Japanese multinational conglomerate Hitachi has shown interest in developing ports in Andhra Pradesh.
 
 
Ebola test results now in 15 minutes!
London, Nov 28 (IANS) A 15-minute blood and saliva test for Ebola is to be tried in Guinea.
 
 
Japanese scientists develop hybrid silk using spider genes
Tokyo, Nov 28 (IANS/EFE) Japanese scientists have developed through genetic engineering using genes from spiders and silkworms a super resistant silk which could be used for textiles as well as in the surgical field, media reported Friday.
 
 
 

Latest from the Network

Apple Black Friday Sale Released
The Apple Black Friday 2014 Sale has launched online at the Apple Store. Apple has announced a huge charity promotion to fight AIDS for Black Friday and Cyber Monday. Apple will donate a portion of the sales the company...
Read more on Apple Balla
 
A look at Black Friday video game deals
All major retailers will be getting in the video game Black Friday spirit. PS4 and XBox One will certainly be two consoles that should garner huge sales but actual games should do good as well. One thing that is for...
Read more on Black Friday Countdown
 
Comics looking for event filled Black Friday
While video games and other electronic gadgets look to be the big draw on deals during Black Friday, comic book readers and fans will be able to find their fair share of deals as well. It has been announced that two...
Read more on Black Friday Countdown
 
Anna Kendrick positive after nude photo leak
Anna Kendrick is looking at the positives following the recent hacking of her nude photos. The 'Pitch Perfect' star - whose naked pictures were posted online by hackers earlier this year alongside other stars like...
Read more on Celebrity Balla
 
Benedict Cumberbatch hates selfies
Benedict Cumberbatch hates selfies. The 'Imitation Game' actor - who recently announced his engagement to Sophie Hunter - won't be personally taking any photos of him and his bride on their wedding day and instead would...
Read more on Celebrity Balla
 
James Franco filmed threesome with Zachary Quinto
James Franco and Zachary Quinto filmed a threesome for their new film 'Michael'. The actors took part in the sexy scene alongside the former 'Desperate Housewives' star Charlie Carver for the upcoming drama, according...
Read more on Movie Balla
 
UN condemns attack on British embassy vehicle
United Nations, Nov 28 (IANS) The UN Security Council (UNSC) has condemned the attack on a British embassy vehicle in Kabul, Afghanistan. "The members of the UNSC expressed their deep sympathy and condolences to the...
Read more on Politics Balla
 
Not all mosquitoes can transmit malaria
New York, Nov 28 (IANS) A genetic study has revealed that certain species of mosquitoes have evolved to better transmit malaria than even some of their close cousins. The study may advance understanding about the...
Read more on Business Balla
 
Rio judge ends Olympic golf course impasse
Rio de Janeiro, Nov 28 (IANS) A Rio de Janeiro judge has rejected a request by public prosecutors to suspend an environmental permit for work on the 2016 Olympic golf course. Judge Eduardo Antonio Klausner said there...
Read more on Sport Balla